Steven J Catani

This inventor holds 28 USPTO granted patents and 34 published patent applications, plus 9 CIPO patents and 10 EPO patents, primarily in Glucose Monitoring. Top assignees: Tate & Lyle Public Limited Company, Heartland Consumer Products LLC, Optum Labs, LLC. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven J Catani. Retrieved from https://idiyas.com/inventor/steven-j-catani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 34)

% Patents Active = 89.3

CIPO Patents = 9 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 17)

Average Co-Inventor Count = 3.6

ph-index = 11

Forward Citations = 348(Granted Patents)

Company Filing History:

6 out of 43

Tate & Lyle Public Limited Company

patents

5 out of 9

Heartland Consumer Products LLC

Unitedhealth Group Incorporated

patents

6. 2 out of 2

Magnolia Nutritionals, L.l.c.

patents

7. 2 out of 50

Neose Technologies, Inc.

patents

8. 1 out of 1

Wellness & Prevention, Inc.

patent

9. 1 out of 834,513

Other

patents

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Glucose Monitoring

Sweetener Compositions

Metabolic Regulation

Continuous Glucose Monitors

Accelerometers

Sucralose Purification

Eating Detection

Sugar Processing

Functional Sugar Polymers

Predictive Monitoring

Automated Message Delivery

High-Intensity Sweeteners

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12635943 - Methods and systems to detect eating (2026-05-26),

2. 12539058 - State-based methods and systems using continuous glucose monitors and accelerometers to regulate glucose levels (2026-02-03),

3. 12207950 - Predictive monitoring of the glucose-insulin endocrine metabolic regulatory system (2025-01-28),

4. 12186109 - Predictive monitoring of the glucose-insulin endocrine metabolic regulatory system (2025-01-07),

5. 11730424 - Methods and systems to detect eating (2023-08-22),

6. 11600121 - Systems and methods for conditional remote unlocking of identified containers (2023-03-07),

7. 11311034 - Synergistic sweetening compositions (2022-04-26),

8. 11306114 - Process for separation, isolation and characterization of steviol glycosides (2022-04-19),

9. 11185260 - State-based methods and systems using continuous glucose monitors and accelerometers to regulate glucose levels (2021-11-30),

10. 11064942 - Methods and systems to detect eating (2021-07-20),

11. 11045401 - Partial melt co-crystallization compositions (2021-06-29),

12. 10092026 - Enhanced natural sweetener and method of making (2018-10-09),

13. 10085474 - Method of making an enhanced natural sweetener (2018-10-02),

14. 8694594 - Method and system for automated team support message delivery (2014-04-08),

15. 8017767 - Sucralose composition (2011-09-13),

Title: Steven J Catani: Innovator in Glucose-Insulin Regulation

Introduction

Steven J Catani is an accomplished inventor based in Athens, GA, with an impressive record of 26 patents to his name. His innovative contributions particularly enhance our understanding and monitoring of metabolic systems, focusing on the crucial glucose-insulin regulatory mechanisms that impact human health.

Latest Patents

Among his latest patents, Steven has developed a methodology for the predictive monitoring of the glucose-insulin endocrine metabolic regulatory system. This invention addresses the pressing need for more effective data analysis solutions in the realm of metabolic regulation. By employing advanced techniques such as glucose surge excursion detections, steady-state glucose-insulin machine learning models, and parameter space refinement machine learning models, his work aims to revolutionize the way predictive data analysis is conducted in this critical area of health management.

Career Highlights

Throughout his career, Steven has been associated with notable companies such as Tate & Lyle Public Limited Company and Heartland Consumer Products LLC. His tenure in these organizations has allowed him to refine his skills and contribute significantly to the field of metabolic regulation and predictive analytics.

Collaborations

Steven has collaborated with esteemed colleagues, including Juan L Navia and Stephen A Roth, which has likely contributed to the depth and breadth of his innovative work. These collaborations emphasize the importance of teamwork in the advancement of technological solutions in healthcare.

Conclusion

Steven J Catani continues to be a pivotal figure in the field of innovations related to glucose-insulin regulation. His dedication to enhancing predictive monitoring through advanced data analysis solutions reflects the vital intersection of technology and health. With his extensive experience and innovative mindset, the future of metabolic regulation looks promising under his influence.

Profile summary based on public USPTO records.